Timothy Wilkin, M.D., M.P.H.

Timothy Wilkin, M.D., M.P.H. is assistant professor of medicine at Weill Medical College of Cornell University. He is a diplomate of the American Board of Internal Medicine, with certifications in internal medicine and infectious diseases.

Dr. Wilkin received his medical degree from the Ohio State University College of Medicine in 1996. He completed an internal medicine residency at the University of Chicago Hospitals in 1999, and an infectious diseases fellowship at Columbia-Presbyterian Medical Center in 2002. In May of 2002 Dr. Wilkin received his M.P.H. from Columbia University.

Dr. Wilkin's research to date has focused on an array of HIV-related topics. He has presented at several major HIV conferences on issues ranging from anal lesions in HIV-positive men to the efficacy of darunavir in treatment experienced patients. His latest research project is a NIAID-funded study investigating anal human papillomavirus infection in HIV-positive and HIV-negative men.

Latest by Timothy Wilkin, M.D., M.P.H.

Promo Image

Anal Cancer Increasing Among People Living With HIV

Why Screen for Anal Cancer in HIV-Positive Patients?

Anal cancer is emerging as a common non-AIDS defining cancer in HIV-positive people. Anal cancer, like cervical cancer, is caused by infection with high-risk types of human papillomavirus (HPV) --...

Promo Image

Switching Antiretroviral Therapy: Why, When and How

Introduction Acute Toxicities Chronic Toxicities Lipoatrophy Central Fat Accumulation Dyslipidemia Insulin Resistance/Diabetes Mellitus Life-Threatening Toxicities Adherence/Quality of Life Changing ART in Patients With Virologic ...

Promo Image

Detecting Primary HIV Infection: Important for Prevention and, Extremely Rarely, Treatment as Well

New research presented at the 13th Conference on Retroviruses and Opportunistic Infections (CROI 2006) lends further support to procedures that can identify cases of primary or acute HIV infection. Not only can the detection of primary HIV help publi...

Promo Image

Small Study Suggests Genotypic Resistance Tests Maintain Accuracy Even When Viral Load Is Below 1,000

U.S. treatment guidelines advise against the use of genotypic resistance tests when a patient’s viral load is below 1,000. But if a patient has persistent, low-level viremia and emerging resistance is a concern, can a genotype still be useful?

A sma...

Promo Image

Two NRTIs or Three? Makes No Difference When Taken With Efavirenz, ACTG 5095 Finds

When prescribing the potent antiretroviral efavirenz (EFV, Sustiva, Stocrin) as part of a first-line treatment regimen, there is no discernible difference between completing the regimen with two nucleoside reverse transcriptase inhibitors (NRTIs) or ...

Promo Image
Conference Coverage

Twice-Daily Massage Can Reduce Papule Formation Among HIV-Infected Patients Receiving Poly-L-Lactic Acid Injections

Lipoatrophy, the loss of subcutaneous fat in the face and extremities, is a common problem among people living with HIV. Common though it may be, however, the condition is often distressful and stigmatizing, and effective treatments are few and far b...

Promo Image

New Research Explores Potential Value of Therapeutic Drug Monitoring

The utility of therapeutic drug monitoring (TDM) is still controversial. While common in Europe, it has not yet become part of standard clinical practice in the United States mostly because no studies have shown a definitive benefit to TDM that justi...

Promo Image
Conference Coverage

Odds and Ends From CROI 2005: CD4+ Testing, Enfuvirtide Site Reactions, Erectile Dysfunction and Cancers

Introduction PointCare: A CD4+ Cell Test for Resource-Limited Settings Severe Enfuvirtide Injection Site Reactions Tied to Lack of Subcutaneous Fat Erectile Dysfunction Underdiagnosed Among HIV-Infected Men Good News, Bad Situation: HAART I...

Promo Image
Lipodystrophy/Body Fat

FRAM Study Finds a Lack of Association Between Lipoatrophy and Central Fat Gain

Losses and Gains: Insights From the Preliminary Results of the Fat Redistribution and Metabolic Change in HIV Infection Study (FRAM) (Institutional Symposium -- NIH) Chairperson: Fulvia Veronese, Office of AIDS Research, National Institutes of ...

Promo Image

Significant Association Found Between Oral Contraceptive Use and HIV Acquisition

Hormonal Contraception and Risk of HIV-1 Acquisition: Results of a 10-Year Prospective Study (Oral 83) Authored by L. Lavreys, J.M. Baeten, H.L. Martin Jr., J.K. Kreiss, K. Mandaliya, J. Ndinya-Achola, J. Overbaugh

Lavreys et al. updated their...